INS and type 2 diabetes mellitus: This may reflect uncoupling of peripheral insulin resistance and insulin secretion among patients with advanced metabolic disease, reflective of β-cell dysfunction among patients with severe or longstanding T2DM, and suggests that insulin itself may not be direct driver of the inflammation-metaplasia-dysplasia sequence in EAC.